Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03727347 · ClinicalTrials.gov registry record · NA
Posterior Nasal Nerve (PNN) Rhinitis Study
A NA study, sponsored by Aerin Medical.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03727347: Completed NA study, sponsored by Aerin Medical.
NCT03727347 is a NA study that has completed, run by Aerin Medical. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03727347, a NA study, has completed, sponsored by Aerin Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Evaluation of the Aerin Medical Device used for the treatment of chronic rhinitis
Primary Outcome
Mean change in Reflective Total Nasal Symptoms Score (rTNSS) from baseline to 12 weeks post-study procedure. Improvement (12 week score - baseline score) is signified by a negative value. The Reflective Total Nasal Symptom Score (rTNSS) is a patient self reported questionnaire of four nasal symptoms: rhinitis, nasal congestion, nasal itching and sneezing. Patients will report their symptoms reflected or felt over the last 12 hours. Total scores can range from 0 to 12. A higher score indicates i
Interventions
- DEVICE InSeca Stylus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2020-09-17 |
| Phase | NA |
What the finished NCT03727347 record still lists
NCT03727347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which InSeca Stylus is the first listed.
NCT03727347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03727347 about?
NCT03727347 is a clinical study titled "Posterior Nasal Nerve (PNN) Rhinitis Study". Evaluation of the Aerin Medical Device used for the treatment of chronic rhinitis
What is the current status of trial NCT03727347?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-10-16. Estimated completion is 2020-09-17.
What interventions are being tested in trial NCT03727347?
The interventions under investigation include: InSeca Stylus (DEVICE).
Who is sponsoring clinical trial NCT03727347?
This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03727347's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI